We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $573M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
-9.73%
1 Year Est. Return
+21.74%
3 Year Est. Return
+62.9%
5 Year Est. Return
+80.86%
10 Year Est. Return
+253.69%
AUM
$268M
AUM Growth
-$28.5M
Cap. Flow
+$3.48M
Cap. Flow %
1.3%
Top 10 Hldgs %
37.03%
Holding
101
New
2
Increased
43
Reduced
32
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 19.35%
2 Industrials 14.17%
3 Technology 13.53%
4 Consumer Staples 11.58%
5 Energy 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.93T
$15.5M 5.79%
152,707
+6,925
+5% +$742K
JNJ icon
2
Johnson & Johnson
JNJ
$609B
$12.5M 4.68%
97,145
+1,648
+2% +$230K
INTC icon
3
Intel
INTC
$478B
$9.72M 3.63%
207,139
+2,271
+1% +$106K
IVV icon
4
iShares Core S&P 500 ETF
IVV
$881B
$9.7M 3.62%
38,566
+293
+0.8% +$79.6K
PG icon
5
Procter & Gamble
PG
$349B
$9.48M 3.54%
103,185
-852
-0.8% -$76.2K
UPS icon
6
United Parcel Service
UPS
$100B
$9.36M 3.5%
96,012
-1,015
-1% -$110K
IJH icon
7
iShares Core S&P Mid-Cap ETF
IJH
$122B
$9.13M 3.41%
274,850
-3,305
-1% -$121K
PFE icon
8
Pfizer
PFE
$143B
$8.67M 3.24%
209,371
-24
-0% -$996
MRK icon
9
Merck
MRK
$315B
$7.57M 2.82%
103,761
+364
+0.4% +$25.7K
XOM icon
10
ExxonMobil
XOM
$611B
$7.48M 2.79%
109,666
-8,628
-7% -$677K
ABBV icon
11
AbbVie
ABBV
$450B
$6.9M 2.58%
74,820
+18,516
+33% +$1.63M
WMT icon
12
Walmart Inc
WMT
$909B
$6.59M 2.46%
212,100
+36,015
+20% +$1.15M
BA icon
13
Boeing
BA
$169B
$6.54M 2.44%
20,287
+193
+1% +$66.7K
DD icon
14
DuPont de Nemours
DD
$18.3B
$6.39M 2.39%
47,201
-1,031
-2% -$148K
CSCO icon
15
Cisco
CSCO
$441B
$6.2M 2.32%
143,122
+1,544
+1% +$70.7K
WFC icon
16
Wells Fargo
WFC
$265B
$5.76M 2.15%
125,045
-13,177
-10% -$675K
CVX icon
17
Chevron
CVX
$373B
$5.67M 2.12%
52,152
+118
+0.2% +$13.7K
MCD icon
18
McDonald's
MCD
$190B
$5.5M 2.05%
30,950
+416
+1% +$73.8K
ABT icon
19
Abbott
ABT
$175B
$5.22M 1.95%
72,171
+16,722
+30% +$1.18M
IBM icon
20
IBM
IBM
$200B
$4.81M 1.8%
44,279
+928
+2% +$111K
KO icon
21
Coca-Cola
KO
$351B
$4.79M 1.79%
101,159
+72
+0.1% +$3.45K
EMR icon
22
Emerson Electric
EMR
$78.2B
$4.79M 1.79%
80,116
-298
-0.4% -$20.1K
USB icon
23
US Bancorp
USB
$98.4B
$4.43M 1.65%
96,890
+9,518
+11% +$490K
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
$4.36M 1.63%
63,867
+20,260
+46% +$1.57M
BP icon
25
BP
BP
$108B
$4.36M 1.63%
118,488
+1,170
+1% +$46.7K

Similar funds

Lynch & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Lynch & Associates held 101 positions worth $268M, down 9.6% from $296M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Lynch & Associates's Q4 2018 filing shows 2 new, 43 increased, 32 reduced and 9 closed positions. Its largest new stake was iShares Russell Mid-Cap ETF: 4,949 shares worth $230K. The largest sale was Vectren Corporation, an estimated $1.22M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • Lynch & Associates's largest Q4 2018 buy was iShares Russell Mid-Cap ETF: 4,949 shares worth $230K.
  • Lynch & Associates added most to AbbVie in Q4 2018, an estimated $1.63M increase.
  • Lynch & Associates's biggest Q4 2018 reduction was Vectren Corporation, cutting an estimated $1.22M.
  • Lynch & Associates fully exited SLB Ltd in Q4 2018, selling an estimated $777K.
  • Lynch & Associates's ten largest holdings make up 37% of its $268M portfolio in Q4 2018.
  • Lynch & Associates opened 2 new positions and closed 9 in Q4 2018.
  • Lynch & Associates's portfolio value fell 9.6% quarter-over-quarter to $268M.

Based on Lynch & Associates's 13F filing for Q4 2018, filed 10 Jan 2019.